Navigating a lung cancer diagnosis can be overwhelming. If you’re looking for general information, tips, and guidance, this section can give you an idea of what to expect from diagnosis through treatment.
To get more specific information about your type of lung cancer, start by learning about the differences between non-small cell lung cancer and small cell lung cancer. Additionally, the LUNGevity Patient Gateways can serve as your central hub for information, resources, and the latest news about your specific type of lung cancer—whether or not you have a known biomarker.
The Patient Journey
Prediagnosis
Screening
Diagnostic Testing
Diagnosis and Staging
- Non-small cell lung cancer: adenocarcinoma, squamous, large cell
- Small cell lung cancer
Diagnosis by biomarker profile
- Molecular driver mutations: EGFR, ALK, ROS1, BRAF V600E, other
- PD-L1 for immunotherapy
Treatment (1st-line, 2nd-line, and beyond)
- Surgery
- Radiation therapy
- Chemotherapy
- Targeted therapy
- Immunotherapy
- Combination therapy
- Clinical trials
- Angiogenesis inhibitors
Monitoring
- Symptom management
- Side-effect management
- Surveillance
- Repeat biopsy
May repeat diagnostic testing